Mining and land reforms draw both corporate flack and international calls for investment treaty termination

The business community needs to get behind a stronger supply chain due diligence law

Canada should join Australia and New Zealand in neutralizing lopsided corporate protections in CPTPP

Commitments to “inclusive” trade are meaningless if they support violations of international law.

Is the new Coalition of Trade Ministers on Climate a branding exercise, or a potentially useful tool?

Canada should agree with the U.S. that TC Energy has no NAFTA case against the cancellation of its Keystone XL pipeline

This week’s North American Leaders’ summit is soured by dubious challenges to Mexican food and energy sovereignty

Trade tensions surround prospective launch of Europe’s Carbon Border Adjustment Mechanism

Forestry-related firms made regular use of NAFTA’s controversial but expiring investor-state dispute settlement process. Why is Canada opening the door to ISDS claims from Indonesian forestry giants?

Manifestement, la mise en pratique des licences obligatoires est loin d’être une panacée.

Workers achieved a long-fought-for trade victory in the 2022 federal budget: trade unions will soon have the right to file trade complaints against unfair imports, something only domestic producers could do before now.

This July marked the second anniversary of the new Canada-United States-Mexico Agreement (CUSMA), the renegotiated North American Free Trade Agreement (NAFTA).

Canada’s trade preference programs should be improved to raise living standards and improve working conditions and environmental policies

In some areas, the Comprehensive Economic and Trade Agreement (CETA) is worse than we predicted. We present five reasons why we’re not celebrating its fifth anniversary.

Trade agreement doesn't age well in a post-pandemic reality, with little mention of worker protections, environmental policy, or critical infrastructure.

Corporate lobbying and WTO pressure-cooker tactics killed the TRIPS waiver. Countries must find the courage to take on Big Pharma at home.